Commercialization: Page
-
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by Louise Anderson Time to Bundle Up Pharmaceutical companies are facing increased competition and are now taking a lead from other industries, such as telecommunications, and looking to a bundled sales approach. In so doing, the sales organizations are moving to a model of team selli...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
PharmaTrax Cardiovascular Drug Market to Top $100 Billion by 2008 The worldwide market for prescription cardiovascular medications, which topped $75 billion in 2004, will surpass the $100 billion mark by 2008, according to a new report released by Kalorama Information titled The Worldwide M...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies E-media PhRMA Website Educates Consumers on the Risks of Importing Drugs Citing a growing body of information that opening the U.S. borders to foreign drugs is risky and unsafe, the Pharmaceutical Research and Manufact...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The spirit of giving Fifth Annual PharmaLinx Charity Golf Outing Linda Beneze from PHT Corp., a gold sponsor of the event, and Taren Grom, editor of PharmaVOICE, take a moment during the Fifth Annual PharmaLinx Charity Golf Outing. The pharmaceutical and life-sciences industries have on...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Driving Sales with Data
Pharmaceutical and device manufacturers are constantly seeking new ways to better communicate the value of their products. Phase IV studies have been the typical means to confirm clinical safety and efficacy, and to understand what happens in “real-world” settings. But, according to F. Randy Voge...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Agency Account Executive and the Industry Product Manager: Two Sides of the Same Coin
Mark Perlotto, Executive VP, General Manager The Agency Account Executive and the Industry Product Manager: Two Sides of the Same Coin People often draw an imaginary line between “agency people” and “industry people” — believing that individuals are cut out for one “side” or the other. Whi...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Integrated Marketing Communications: Understanding the Premise, Fulfilling the Promise
Integrated Marketing Communications: Understanding the Premise, Fulfilling the Promise Gary Bridi, Managing Director, S&H NJ Integrated marketing communications (IMC) is not a new idea. But while it has been discussed in academic and industry circles since the early 90s, its full benefi...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What Do You Look for in a Widget?
What Do You Look for in a Widget? Warren A. Dardine President, Clinical Education Associates, a division of Dimensional HealthCare Inc. Suppose you were in the market to buy a new widget. You would probably read manufacturer information regarding the superiority of the newer widget compar...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Pharma's Opportunity: Branding for the Long Haul
Branding Pharma’s Opportunity: Branding for the Long Haul By Kristen Spensieri The vital importance of branding has long been standard practice in the consumer marketplace, with the most successful companies creating brands that stand for infinitely more than individual products or, in som...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Medicare Part D is launching in a few months and is expected to pump $540 million in benefits over the next 10 years into the healthcare industry, making the government the largest purchaser in the United States. After a long buildup period, the marketing of Medicare Part D prescription drug b...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Let the Science Tell the Story
Communications Larry Wright, Ph.D. VP, Account Services and Business Development The molecular science involved in creating an agent, as well as the biological rationale for the agent’s use intrigues that “little bit of biologist” in each and every healthcare profes...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool PharmaVOICE October 2005 Executive Appointments and Promotions in the Healthcare Industry Pharma POOL Dr. Jacqueline Crew Paul Medeiros Dr. John O’Mullane David Wing Schering-Plough Adds Executive Leadership Schering-Plough, a global science-based healthcare company bas...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Management of Customer Relationship Management
The Management of Customer Relationship Management By Elisabeth Pena Villarroel Responding to the customers’ needs is more important than ever for pharmaceutical companies. As patients seek more information and doctors continue to be crunched for time, targeted, meaningful messages that add...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Louis C. Arp Dr. Lyn D. Olson Eisai Announces Executive Appointments Eisai, a pharmaceutical company based in Teaneck, N.J., has appointed Louis C. Arp as VP of production operations and Lyn D. Olson, Ph.D., as VP of quality at its pharmaceutical production and formulation research an...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Exit Pied Piper. Enter Johnny Appleseed.
Exit Pied Piper. Enter Johnny Appleseed. 4 Reasons to Embrace Personalized Communication While Preparing for Personalized Medicine Eve Dryer President, Vox Medica Healthcare Public Relations Chief Strategy Officer/Senior VP, Vox Medica Pharmaceutical compa...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The numbers are staggering: 70% of all medical prescriptions go unconsumed, leading to $77 billion in excess healthcare costs each year; 30% to 85% of patients may disregard refills, depending on the disease and treatment regimen; and up to 20% of all hospital and nursing home admissions and 125 ...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Kevin Hrusovsky -- Bucking the Trend
Kevin Hrusovsky — Bucking the Trend By Kim Ribbink From the playing fields to football fandom to building teams to the corporate boardroom, Kevin Hrusovsky carries an infectious enthusiasm for everything he does. And it’s that energy that is helping to drive innovation at Caliper Life Sciences. “...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
What’s New New healthcare-related products, services, and companies GfK Group Integrates U.S. Healthcare Businesses GfK Group has consolidated its U.S. healthcare activities under GfK U.S. HealthCare Companies. This move follows GfK’s acquisition of NOP World, as well as its full acquisition of G...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Patients’ Channel Preferences Vary by Personal Situation In the past few years, patients have become increasingly more informed and sophisticated. They continue to experience increased time pressures and have more access to information about prescription brands than ever thanks to the Internet. T...
By David Zaritsky and Julian Parreño • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Internet Deemed the Most Trusted Media Source by Healthcare Consumers A new study of consumer attitudes toward healthcare information finds that the Internet is regarded as the most trusted media source for consumers, decisively outstripping offline media when consumers want credible health infor...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Branding With Both Sides of the Brain: The Integration of Science and Promotion in Pharmaceutical Marketing
Agency Services Branding With Both Sides of the Brain: The Integration of Science and Promotion in Pharmaceutical Marketing Brands connect with both sides of the brain equally well by simultaneously appealing to rational motivators and answering emotional needs. Larry Iaquinto ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Successful Life-Cycle Results Come From Reversing The Process
Successful Life-Cycle Results Come From Reversing The Process William S. Machtiger, President Many efficacious products have recently or will soon reach the end of their patent protected life cycle. Major diseases related to the cardiovascular system, metabolic disorders, gastrointestinal compl...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Optimizing Your Agencies' Role in Prelaunch Planning
DVC HealthCare Optimizing Your Agencies’ Role in Prelaunch Planning New product teams should consider developing an integrated communications plan with the full involvement of their key agency partners to optimize planning, draw benefit from more expertise and experi...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
VIEW on Marketing A Compilation of Insider Views on the Dynamic Marketing Sector PharmaVOICE September 2004 Volume 2 NUmber 3 www.pharmavoice.com Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
In Or Out: Outsourcing In Today's Biopharmaceutical Industry
In Or Out: Outsourcing In Today’s Biopharmaceutical Industry Outsourcing Outsourcing — the hottest buzzword in business — is a paradox of modern enterprise. It’s a strategy that is so pervasive that nearly every company on earth practices it in some fashion, but is seen as so innovative that sm...
By PharmaVoice Team • Jan. 2, 2008
Previous
